ELQ-596, identified by its CAS number 3023709-98-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in treating viral infections. It is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. ELQ-596 has been studied for its mechanism of action, which involves inhibiting viral replication, making it a candidate for antiviral therapies. The compound's solubility, stability, and pharmacokinetic properties are critical for its effectiveness and safety profile. Additionally, research has focused on its toxicity and side effects, which are essential considerations in drug development. As with many experimental compounds, ongoing studies aim to elucidate its full therapeutic potential and optimize its formulation for clinical use. Overall, ELQ-596 represents a promising area of research in the quest for effective antiviral agents.

ELQ-596

3023709-98-7: ELQ-596, identified by its CAS number 3023709-98-7, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in treating viral infections. It is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. ELQ-596 has been studied for its mechanism of action, which involves inhibiting viral replication, making it a candidate for antiviral therapies. The compound's solubility, stability, and pharmacokinetic properties are critical for its effectiveness and safety profile. Additionally, research has focused on its toxicity and side effects, which are essential considerations in drug development. As with many experimental compounds, ongoing studies aim to elucidate its full therapeutic potential and optimize its formulation for clinical use. Overall, ELQ-596 represents a promising area of research in the quest for effective antiviral agents.

ELQ-596, a quinolone derivative, exhibits antimicrobial activity against several protozoan parasites, including the intraerythrocytic parasites Plasmodium and Babesia. ELQ-596 attenuates babesiosis in immunosuppressed mice [1].

CAS 3023709-98-7

ELQ-596

ELQ-596

Ref: TM-T86363